Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...
9h
Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne ...
In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Entrada Therapeutics Inc (TRDA – Research Report), ...
Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy - - Follows recently received ...
Shares of Entrada Therapeutics rose after regulators removed a clinical hold and said its lead product candidate could be studied as a treatment for Duchenne muscular dystrophy. The stock was up 9.5% ...
Entrada Therapeutics (TRDA) announced that the United States Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and ...
Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy – – Follows recently received ...
The St. Johns County Planning and Zoning Agency is pushing forward a project to build a cell tower in St. Augustine South, ...
Kapta Space, a radar technology startup based in Seattle, raised $5 million in a seed round led by MetaVC Partners.
WASHINGTON — After nearly three years operating in stealth mode, Seattle-based startup Kapta Space emerged on Feb. 21, announcing plans to demonstrate metasurface antenna technology for space-based ...
Kapta Space plans to innovate space radar technology, enhancing precision and reducing imaging costs with electronically ...
Oswaldo Rivas Reubicarán la Entrada Peatonal de la Garita de Calexico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback